Long-term safety, potential adverse effects, and inconsistent clinical outcomes remain challenges that must be addressed
[14] Patients should be cautious about sourcing any unlicensed medicines including retatrutide from unregulated online suppliers, as this carries significant safety risks
Until then, for the millions of cancer patients who also happen to be taking GLP-1s, the question of whether the drug might be helping them remains unanswered
These phenomena also motivate robustness and domain-shift research, cross-platform analyses, and exploration of multilingual or multimodal signals [4, 67, 85, 108]
Cancer Discov (2013) 3(3):35062